A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial

C.M. Sackley, C. Rick*, P. Au, M.C. Brady, G. Beaton, C. Burton, M. Caulfield, S. Dickson, F. Dowling, M. Hughes, N. Ives, S. Jowett, P. Masterson-Algar, A. Nicoll, S. Patel, C.H. Smith, R. Woolley, C.E. Clarke, PD COMM Collaborative Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
77 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences